FXN and Friedreich ataxia: In previous work we observed significant decreases in frataxin mRNA levels in multiple human cell lines as well as primary human fibroblasts and lymphoblasts derived from Friedreich ataxia patients and controls, when treated with the iron chelator desferrioxamine (DFO) [21].